Lori Ferrins, Ph.D.
Affiliations: | 2015- | Northeastern University, Boston, MA, United States |
Area:
TrypanosomiasisGoogle:
"Lori Ferrins"Mean distance: 9.62 | S | N | B | C | P |
Parents
Sign in to add mentorJonathan Baell | grad student | 2010-2015 | Monash University |
Michael P. Pollastri | post-doc | 2015- | Northeastern University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
de Oliveira RG, Cruz LR, Dessoy MA, et al. (2025) Discovery and Early Optimization of 1-Indole-2-carboxamides with Anti- Activity. Journal of Medicinal Chemistry |
Toynton A, Ferrins L, Newson HL, et al. (2025) Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas. Rsc Medicinal Chemistry |
Spaulding A, Sharma A, Giardini MA, et al. (2025) Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic Agents. Acs Infectious Diseases |
Ferrins L, Diaz R, Cordon-Obras C, et al. (2024) Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of . Journal of Medicinal Chemistry. 67: 13985-14006 |
Klug DM, Tse EG, Silva DG, et al. (2023) Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant . Acs Infectious Diseases |
Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1304196 |
Boby ML, Fearon D, Ferla M, et al. (2023) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science (New York, N.Y.). 382: eabo7201 |
Dichiara M, Simpson QJ, Quotadamo A, et al. (2023) Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis. Acs Infectious Diseases |
Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1149145 |
Sanders BC, Pokhrel S, Labbe AD, et al. (2023) Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. Nature Communications. 14: 1733 |